P Vague

Clearance of Tissue Plasminogen Activator (TPA) and TPA/Plasminogen Activator Inhibitor Type 1 (PAI-1) Complex

Wayne L. Chandler, Marie‐Christine Alessi, M.F. Aillaud et al. · Circulation · 1997 · 245 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +16

Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response.

I. Juhan‐Vague, Marie‐Christine Alessi, Patrick Joly et al. · Arteriosclerosis An Official Journal of the American Heart Association Inc · 1989 · 203 citations · Full text

Medicine, Cardiology, Physiology +13

Insulin detemir used in basal‐bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin

I. De Leeuw, P Vague, J. L. Selam et al. · Diabetes Obesity and Metabolism · 2004 · 179 citations

Medicine, Endocrinology, Internal Medicine +16

Metformin Decreases the High Plasminogen Activator Inhibition Capacity, Plasma Insulin and Triglyceride Levels in Non-Diabetic Obese Subjects

P Vague, I. Juhan‐Vague, Marie‐Christine Alessi et al. · Thrombosis and Haemostasis · 1987 · 166 citations

Medicine, Endocrinology, Pharmacology +13

Fat distribution and plasminogen activator inhibitor activity in nondiabetic obese women

P Vague, I. Juhan‐Vague, V. Chabert et al. · Metabolism · 1989 · 128 citations

Medicine, Biochemistry, Endocrinology +12